Benzinga posted 9:55am today.. Unconfirmed market chatter that FDA may approve early Intercept treatment for NASH between March 20-22.. Hard to believe as phase 3 hasn't even started, but that's what was posted.. Just query Benzinga Intercept February 27 if you want see it for yourself..
I know.. Surprised to even see something like this.. So is Benzinga like a Zacks ?? Never pay attention to them ??
I mean come on... earnings ??? They don't have a product yet.. Earnings is the least important factor now.. FDA approved collaborative Phase 3 testing.. now that will move the stock..
Well, I've held this for almost 8 years now so a few more months won't kill me.. That being said.. Come on already !!!!!!!!!!!
Approximately 8 years for me.. I was close to writing this off, but my other biotech plays allowed me to continue to hold.. Now I will wait until this completely plays out..
Short as much as you can afford.. Guaranteed..??.. Not in the stock market.. Ever...
I'm not greedy at all.. $100 a share is fine by me.. haha
Possible, but not as likely now.. One of my biggest fears was a stock offering.. For whatever reason, this is being taken as a huge positive.. Biggest risk now is if the French Souffle pushing GENFIT turns out to be right..
Your are dead wrong.. You will get far less based on what happens historically.. And it will take years..